Patients with CKD who also have poorly controlled diabetes, use large doses of insulin or secretagogues, are at risk for hypoglycaemia, or have had a recent episode of diabetic ketoacidosis (DKA) face significant risks if they choose to fast. This evidence concerns the gene INS and diabetic ketoacidosis.